01.12.2011 | Case report | Ausgabe 1/2011 Open Access
Fulminant hemophagocytic lymphohistiocytosis induced by pandemic A (H1N1) influenza: a case report
- Zeitschrift:
- Journal of Medical Case Reports > Ausgabe 1/2011
Wichtige Hinweise
Electronic supplementary material
The online version of this article (doi:10.1186/1752-1947-5-280) contains supplementary material, which is available to authorized users.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
CW analyzed the clinical and biological patient data and partially wrote the paper; AC and AW performed the histological examination and interpretation; MJG participated in patient data interpretation and writing of the manuscript; FF initiated the patient analysis and report, and wrote the final version of the manuscript. All authors read and approved the final manuscript.
Abstract
Introduction
Hemophagocytic lymphohistiocytosis induced by viral diseases is a well recognized entity. Severe forms of H5N1 influenza are known to be associated with symptoms very similar to a reactive hemophagocytic syndrome. We report a case of fulminant lymphohistiocytosis associated with the pandemic A (H1N1) variant.
Case presentation
A 42-year-old Caucasian woman developed a syndrome of fatal hemophagocytic lymphohistiocytosis shortly after H1N1 influenza. Initial symptoms of the viral disease were unusual, with acute abdominal involvement. Our patient's course was complicated by diffuse skin rash and ileal ischemia. Our patient died of refractory shock and multi-organ failure. Skin, ileum and colon histology was consistent with an acute apoptosis combined with an increased cellular regeneration.
Conclusions
Influenza may be complicated by severe forms of hemophagocytic lymphohistiocytosis. To ensure early recognition and treatment, physicians should be aware of the possible induction of the syndrome by the novel H1N1 variant. The rapid occurrence of a multi-organ involvement with evocative biological features of macrophage activation should alert clinicians.